Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Hematology"
DOI: 10.1007/s00277-022-04800-3
Abstract: Hairy cell leukemia (HCL) is a rare hematologic disorder characterized by pancytopenia and splenomegaly for which a single course of cladribine is highly effective in inducing complete remissions. However, there is limited real-world data on… read more here.
Keywords: cladribine; hairy cell; treated cladribine; cell leukemia ... See more keywords
Prevalence of disability improvement in relapsing–remitting multiple sclerosis patients treated with cladribine tablets
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15316
Abstract: The aim was to show the application of the prevalence estimator of Expanded Disability Status Scale (EDSS) improvement over time in patients treated with cladribine tablets in the phase III CLARITY/CLARITY extension trials. read more here.
Keywords: improvement; prevalence disability; treated cladribine; patients treated ... See more keywords